PMID- 31898280 OWN - NLM STAT- MEDLINE DCOM- 20201123 LR - 20210110 IS - 1473-4230 (Electronic) IS - 1473-4222 (Linking) VI - 19 IP - 2 DP - 2020 Apr TI - Selective Cerebellar Atrophy Associates with Depression and Fatigue in the Early Phases of Relapse-Onset Multiple Sclerosis. PG - 192-200 LID - 10.1007/s12311-019-01096-4 [doi] AB - Cerebellar dysfunctions have been associated to depressive disorders and cognitive impairment in neurodegenerative diseases. The objective is to analyze the associations between cerebellar atrophy, depression, and fatigue in the early phases of relapse-onset multiple sclerosis (RRMS). Sixty-one RRMS patients and 50 healthy controls (HC) were enrolled and clinically evaluated by means of expanded disability status scale (EDSS), Rao's brief repeatable battery of neuropsychological tests (BRB-NT), Delis-Kaplan executive function system sorting test, beck depression inventory II (BDI-II), and fatigue severity scale (FSS). The relationships between MRI variables and clinical scores were assessed. Depressed RRMS (dRRMS) had significantly lower Vermis Crus I volume compared with not depressed RRMS (ndRRMS) (p = 0.009). Vermis Crus I volume was lower in dRRMS suffering from fatigue than in ndRRMS without fatigue (p = 0.01). The hierarchical regression models which included demographic and clinical data (age, sex, and disease duration, FSS or BDI-II) and cerebellar volumes disclosed that cerebellar lobule right V atrophy explained an increase of 4% of the variability in FSS (p = 0.25) and Vermis Crus I atrophy explained an increase of 6% of variability in BDI-II (p = 0.049). Since clinical onset, atrophy of specific cerebellar lobules associates with important clinical aspects of RRMS. Cerebellar pathology may be one of the determinants of fatigue and depression that contribute to worsen disability in RRMS. FAU - Lazzarotto, Andrea AU - Lazzarotto A AUID- ORCID: 0000-0002-5109-8533 AD - Multiple Sclerosis Centre of the Veneto Region, Padua, Italy. andrea.lazzarotto89@gmail.com. AD - Department of Neuroscience, University Hospital of Padua, Giustiniani 5, 35100, Padua, Italy. andrea.lazzarotto89@gmail.com. AD - Padova Neuroscience Center-PNC, Padua, Italy. andrea.lazzarotto89@gmail.com. FAU - Margoni, Monica AU - Margoni M AD - Multiple Sclerosis Centre of the Veneto Region, Padua, Italy. AD - Department of Neuroscience, University Hospital of Padua, Giustiniani 5, 35100, Padua, Italy. AD - Padova Neuroscience Center-PNC, Padua, Italy. FAU - Franciotta, Silvia AU - Franciotta S AD - Multiple Sclerosis Centre of the Veneto Region, Padua, Italy. AD - Department of Neuroscience, University Hospital of Padua, Giustiniani 5, 35100, Padua, Italy. FAU - Zywicki, Sofia AU - Zywicki S AD - Multiple Sclerosis Centre of the Veneto Region, Padua, Italy. AD - Department of Neuroscience, University Hospital of Padua, Giustiniani 5, 35100, Padua, Italy. FAU - Riccardi, Alice AU - Riccardi A AD - Multiple Sclerosis Centre of the Veneto Region, Padua, Italy. AD - Department of Neuroscience, University Hospital of Padua, Giustiniani 5, 35100, Padua, Italy. FAU - Poggiali, Davide AU - Poggiali D AD - Department of Mathematics, University of Padua, Padua, Italy. FAU - Anglani, Mariagiulia AU - Anglani M AD - Neuroradiology Unit, University Hospital of Padua, Padua, Italy. FAU - Gallo, Paolo AU - Gallo P AD - Multiple Sclerosis Centre of the Veneto Region, Padua, Italy. AD - Department of Neuroscience, University Hospital of Padua, Giustiniani 5, 35100, Padua, Italy. AD - Padova Neuroscience Center-PNC, Padua, Italy. LA - eng PT - Journal Article PL - United States TA - Cerebellum JT - Cerebellum (London, England) JID - 101089443 SB - IM MH - Adolescent MH - Adult MH - Atrophy/pathology MH - Cerebellum/*pathology MH - Depression/*etiology MH - Fatigue/*etiology MH - Female MH - Humans MH - Magnetic Resonance Imaging MH - Male MH - Middle Aged MH - Multiple Sclerosis, Relapsing-Remitting/*complications/*pathology MH - Young Adult OTO - NOTNLM OT - Cerebellum OT - Depression OT - Fatigue OT - Multiple sclerosis OT - Neuroimaging EDAT- 2020/01/04 06:00 MHDA- 2020/11/24 06:00 CRDT- 2020/01/04 06:00 PHST- 2020/01/04 06:00 [pubmed] PHST- 2020/11/24 06:00 [medline] PHST- 2020/01/04 06:00 [entrez] AID - 10.1007/s12311-019-01096-4 [pii] AID - 10.1007/s12311-019-01096-4 [doi] PST - ppublish SO - Cerebellum. 2020 Apr;19(2):192-200. doi: 10.1007/s12311-019-01096-4.